We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Neupogen Biosimilar Shows Good Results in Study
Neupogen Biosimilar Shows Good Results in Study
July 22, 2008
A trial comparing Insmed’s INS-19, a recombinant human granulocyte colony stimulating factor (G-CSF), with Amgen’s neutropenia treatment Neupogen demonstrated the two products were identical, according to Insmed.